UNITY BIOTECHNOLOGY INC (UBX) Stock Analyst Earnings Estimates
NASDAQ:UBX - Nasdaq - US91381U2006 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 4.78M | 240K -94.98% | -100.00% | 39.053M | 52.183M 33.62% | 45.311M -13.17% | 56.687M 25.11% | 85.718M 51.21% | 105.63M 23.23% | 120.18M 13.77% | 126.77M 5.48% | 132.79M 4.75% | ||
| EBITDA YoY % growth | -87.85M -0.99% | -53.79M 38.77% | -55.39M -2.97% | -40.225M 32.69% | -27.538M 26.14% | -40.392M -46.68% | -38.891M 3.72% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -91.3M -1.84% | -56.67M 37.93% | -57.57M -1.59% | -46.864M 33.19% | -37.748M 1.86% | -38.031M -0.75% | -27.777M 26.96% | 5.227M 118.82% | -3.378M -164.62% | 16.448M 586.92% | 26.74M 62.57% | 33.472M 25.18% | 39.843M 19.03% | |
| Operating Margin | N/A | -1,185.56% | -23,987.50% | N/A | -96.66% | -72.88% | -61.30% | 9.22% | -3.94% | 15.57% | 22.25% | 26.40% | 30.00% | |
| EPS YoY % growth | -18.10 4.74% | -10.90 39.78% | -7.06 35.23% | -3.28 63.88% | -1.47 42.25% | -1.40 4.94% | -0.81 42.38% | 0.20 125.04% | 0.14 -30.00% | 0.48 239.29% | 0.62 28.42% | 0.72 17.21% | 0.82 13.29% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.41 -45.97% | -0.31 7.91% | -0.11 64.16% | -0.14 62.79% | -0.18 55.52% | -0.38 -21.61% | -0.38 -245.45% | -0.38 -172.14% |
| Revenue Q2Q % growth | 6.733M | N/A | N/A | 5.959M | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | -7.1M -19.61% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -7.251M -1.87% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.38 42.42% | -0.42 | 0.04 | 8.68% |
| Q2 2024 Q2Q % growth | -0.31 63.53% | -0.47 | 0.16 | 33.56% |
| Q1 2024 Q2Q % growth | -0.34 55.26% | -0.48 | 0.14 | 29.48% |
| Q4 2023 Q2Q % growth | -0.28 72.00% | -0.73 | 0.45 | 61.55% |
| Q3 2023 Q2Q % growth | -0.66 51.47% | -0.97 | 0.31 | 32.05% |
| Q2 2023 Q2Q % growth | -0.85 55.26% | -0.86 | 0.01 | 1.71% |
| Q1 2023 Q2Q % growth | -0.76 72.86% | -1.09 | 0.33 | 30.58% |
| Q4 2022 Q2Q % growth | -1.00 44.44% | -1.06 | 0.06 | 5.55% |
| Q3 2022 Q2Q % growth | -1.36 54.67% | -1.66 | 0.30 | 18.23% |
| Q2 2022 Q2Q % growth | -1.90 40.63% | -2.83 | 0.93 | 32.77% |
| Q1 2022 Q2Q % growth | -2.80 3.45% | -2.60 | -0.20 | -7.77% |
| Q4 2021 Q2Q % growth | -1.80 51.35% | -3.89 | 2.09 | 53.71% |
| Q3 2021 Q2Q % growth | -3.00 42.31% | -3.75 | 0.75 | 20.02% |
| Q2 2021 Q2Q % growth | -3.20 15.79% | -3.10 | -0.10 | -3.07% |
| Q1 2021 Q2Q % growth | -2.90 46.30% | -3.83 | 0.93 | 24.34% |
| Q4 2020 Q2Q % growth | -3.70 5.13% | -4.76 | 1.06 | 22.29% |
| Q3 2020 Q2Q % growth | -5.20 -1.96% | -4.96 | -0.24 | -4.86% |
| Q2 2020 Q2Q % growth | -3.80 32.14% | -5.17 | 1.37 | 26.43% |
| Q1 2020 Q2Q % growth | -5.40 -22.73% | -5.12 | -0.28 | -5.52% |
| Q4 2019 Q2Q % growth | -3.90 | -5.64 | 1.74 | 30.83% |
| Q3 2019 Q2Q % growth | -5.10 | -5.18 | 0.08 | 1.63% |
| Q2 2019 Q2Q % growth | -5.60 | -4.90 | -0.70 | -14.26% |
| Q1 2019 Q2Q % growth | -4.40 | -5.13 | 0.73 | 14.16% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2023 Q2Q % growth | -100.00% | % | ||
| Q4 2022 Q2Q % growth | -100.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 1.62% | 3.28% |
| Revenue | N/A | N/A | -33.33% | N/A |